---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-000765"
form_type: "8-K"
ticker: "TGNT"
cik: "0000846377"
company_name: "Totaligent, Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:10:15.554408+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Totaligent enters acqui-hire LOI with Aetherium Medical; 10% equity stake, no cash

## Summary
- Acquiring Aetherium's team, IP, business plan in exchange for 10% of Totaligent's outstanding common stock as restricted preferred.
- New wholly owned subsidiary Aetherium Medical LLC formed; Assets contributed with no cash consideration at closing.
- Ivan Klarich, Aetherium's CEO, appointed Managing Director of the subsidiary.
- Target closing March 5, 2026; exclusivity through April 5, 2026; definitive agreements to follow.
- Equity subject to milestone-based vesting, 15% escrow holdback for 12 months, and repurchase rights.

## SEC filing metadata
- accession: 0001477932-26-000765
- form_type: 8-K
- ticker: TGNT
- cik: 0000846377
- company_name: Totaligent, Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/0001477932-26-000765-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/totaligent_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-000765
- JSON: https://secwatch.observer/filing/0001477932-26-000765.json
- Plain text: https://secwatch.observer/filing/0001477932-26-000765.txt

## Key facts
- Material Agreements
  Totaligent, Inc. entered into Binding Letter of Intent with Aetherium Medical (effective 2026-02-11).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Aetherium Medical
  - Effective: 2026-02-11
  source text: On February 11, 2026, Totaligent, Inc. (the “Company”) entered into a Binding Letter of Intent (the “LOI”) with Aetherium Medical (“Aetherium”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/0001477932-26-000765-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.